Neumirna Therapeutics ApS — Credit Rating and Financial Key Figures
CVR number: 41696451
A.C. Meyers Vænge 15, 2450 København SV
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | -5 780.77 | -4 660.60 | -5 476.18 | -5 495.94 |
| Employee benefit expenses | -1 420.20 | -1 700.59 | -2 154.21 | -2 794.42 |
| EBIT | -7 200.97 | -6 361.20 | -7 630.39 | -8 290.35 |
| Other financial income | 9.60 | 0.36 | 47.33 | 53.54 |
| Other financial expenses | - 424.10 | - 419.13 | -2 161.62 | - 481.89 |
| Pre-tax profit | -7 615.46 | -6 779.96 | -9 744.68 | -8 718.70 |
| Income taxes | 1 547.10 | 1 487.72 | 1 710.27 | 1 764.50 |
| Net earnings | -6 068.36 | -5 292.25 | -8 034.42 | -6 954.20 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Tangible assets total | ||||
| Investments total | 5.31 | 13.47 | ||
| Long term receivables total | ||||
| Inventories total | ||||
| Prepayments and accrued income | 29.11 | |||
| Current other receivables | 160.50 | 279.75 | 665.73 | 731.16 |
| Current deferred tax assets | 1 547.10 | 1 487.72 | 1 710.27 | 1 764.47 |
| Short term receivables total | 1 707.61 | 1 767.47 | 2 405.10 | 2 495.63 |
| Cash and bank deposits | 4 033.03 | 7 191.11 | 3 849.79 | 3 010.96 |
| Cash and cash equivalents | 4 033.03 | 7 191.11 | 3 849.79 | 3 010.96 |
| Balance sheet total (assets) | 5 745.95 | 8 972.05 | 6 254.89 | 5 506.60 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Share capital | 48.82 | 48.82 | 48.82 | 48.82 |
| Retained earnings | 7 878.25 | 1 809.89 | -3 482.36 | -11 516.77 |
| Profit of the financial year | -6 068.36 | -5 292.25 | -8 034.42 | -6 954.20 |
| Shareholders equity total | 1 858.71 | -3 433.53 | -11 467.95 | -18 422.15 |
| Non-current loans from credit institutions | 7 493.18 | 10 218.25 | ||
| Non-current accruals and deferred income | 683.70 | 155.70 | ||
| Non-current other liabilities | 3 317.75 | |||
| Non-current deferred tax liabilities | 3 588.09 | 5 937.84 | ||
| Non-current liabilities total | 3 317.75 | 11 081.27 | 16 839.79 | 155.70 |
| Current loans from credit institutions | 17 234.77 | |||
| Current trade creditors | 455.39 | 1 160.10 | 660.51 | 2 040.97 |
| Other non-interest bearing current liabilities | 114.09 | 164.21 | 222.54 | 4 233.31 |
| Accruals and deferred income | 264.00 | |||
| Current liabilities total | 569.49 | 1 324.31 | 883.05 | 23 773.05 |
| Balance sheet total (liabilities) | 5 745.95 | 8 972.05 | 6 254.89 | 5 506.60 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.